Arrowhead Pharmaceuticals Inc.

NASDAQ:ARWR  
34.20
+0.87 (+2.61%)
Earnings Announcements

Arrowhead Pharmaceuticals Reports Qtrly Loss Per Share Of $0.41

Published: 05/10/2022 20:59 GMT
Arrowhead Pharmaceuticals Inc. (ARWR) - Arrowhead Pharmaceuticals Reports Fiscal 2022 Second Quarter Results.
Qtrly Loss per Share $0.41.
Q2 Earnings per Share View $-0.08 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $52.61 Million
Adjusted EPS is expected to be -$0.51

Next Quarter Revenue Guidance is expected to be $62.83 Million
Next Quarter EPS Guidance is expected to be -$0.44

More details on our Analysts Page.